Toward Better Management of Merkel Cell Carcinoma Using a Consensus Staging System, New Diagnostic Codes and a Recently Discovered Virus

Actas Dermo-Sifiliograficas

Volumn 100, Issue SUPPL. 2, 2009, Pages 49-54

  Iyer, J G ^a   Koba, S ^a,b   Nghiem, P ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SAGA UNIVERSITY   (Japan)

^c SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

Merkel cell carcinoma; neuroendocrine; skin cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; HUMAN; MERKEL CELL TUMOR; NONHUMAN; POLYOMA VIRUS; PROGNOSIS; RISK FACTOR; SKIN CANCER;

CARCINOMA, MERKEL CELL; CONSENSUS; HUMANS; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS;

EID: 76749129398     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S0001-7310(09)73378-2     Document Type: Article

References (28)

1. Agelli M., and Clegg L.X. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 49 (2003) 832-841
2. Balch C.M., Soong S.J., Gershenwald J.E., Thompson J.F., Reintgen D.S., Cascinelli N., et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 (2001) 3622-3634
3. Goggins W., Daniels G.H., and Tsao H. Elevation of thyroid cancer risk among cutaneous melanoma survivors. Int J Cancer 118 (2006) 185-188
4. Lens M.B., Dawes M., Newton-Bishop J.A., and Goodacre T. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg 89 (2002) 1223-1227
5. Gupta S.G., Wang L.C., Peñas P.F., Gellenthin M., Lee S.J., and Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 142 (2006) 685-690
6. Lemos B., and Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 127 (2007) 2100-2103
7. Hodgson N.C. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 89 (2005) 1-4
8. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3,870 cases: a population based study. J Cutan Pathol. 2009 [in press]
9. Penn I., and First M.R. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 68 (1999) 1717-1721
10. Engels E.A., Frisch M., Goedert J.J., Biggar R.J., and Miller R.W. Merkel cell carcinoma and HIV infection. Lancet 359 (2002) 497-498
11. Heath M., Jaimes N., Lemos B., Mostaghimi A., Wang L.C., Peñas P.F., et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 58 (2008) 375-381
12. Feng H., Shuda M., Chang Y., and Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 (2008) 1096-1100
13. Kassem A., Technau K., Kurz A.K., Pantulu D., Löning M., Kayser G., et al. Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 125 (2009) 356-361
14. Garneski K.M., Warcola A.H., Feng Q., Kiviat N.B., Leonard J.H., and Nghiem P. Merkel Cell Polyomavirus Is More Frequently Present in North American than Australian Merkel Cell Carcinoma Tumors. J Invest Dermatol 129 (2009) 246-248
15. Busam K.J., Jungbluth A.A., Rekthman N., Coit D., Pulitzer M., Bini J., et al. Merkel cell polyomavirus expression in Merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas. Am J Surg Pathol 33 (2009) 1378-1385
16. Tolstov Y.L., Pastrana D.V., Feng H., Becker J.C., Jenkins F.J., Moschos S., et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 125 (2009) 1250-1256
17. Carter J, Paulson K, Wipf G, Miranda D, Madeleine MM, Johnson LG, et al. Antibodies to Merkel cell polyomavirus are associated with Merkel cell carcinoma. J Natl Cancer Inst. 2009 [in press]
18. Yiengpruksawan A., Coit D.G., Thaler H.T., Urmacher C., and Knapper W.K. Merkel cell carcinoma. Prognosis and management. Arch Surg 126 (1991) 1514-1519
19. Allen P.J., Zhang Z.F., and Coit D.G. Surgical management of Merkel cell carcinoma. Ann Surg 229 (1999) 97-105
20. Allen P.J., Bowne W.B., Jaques D.P., Brennan M.F., Busam K., and Coit D.G. Merkel cell carcinoma: prognosis and treatment of pa tients from a single institution. J Clin Oncol 23 (2005) 2300-2309
21. AJCC Cancer Staging Manual. 6th ed. Chicago: Springer; 2002.
22. Clark J.R., Veness M.J., Gilbert R., O'Brien C.J., and Gullane P.J. Merkel cell carcinoma of the head and neck: Is adjuvant radiotherapy necessary?. Head Neck 29 (2007) 249-257
23. AJCC Cancer Staging Manual. Merkel Cell Carcinoma. Chapter 30. 7th ed. Chicago: Springer; 2009.
24. Lemos BD, Storer BE, Iyer JG, Phillips JL, Bichakjian CK, Fang LC, et al. Development of the first American Joint Committee on Cancer Staging System for Merkel cell carcinoma based on prognostic factors analysis of 5,823 National Cancer Data Base cases Submitted.
25. Criscione V.D., and Weinstock M.A. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol 143 (2007) 854-859
26. Miller S.J., Alam M., Andersen J., Berg D., Bichakjian C.K., Bowen G., et al. Merkel cell carcinoma. J Natl Compr Canc Netw 7 (2009) 322-332
27. Lewis K.G., Weinstock M.A., Weaver A.L., and Otley C.C. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 142 (2006) 693-700
28. Mortier L., Mirabel X., Fournier C., Piette F., and Lartigau E. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol 139 (2003) 1587-1590